Development of Biopolymer-Lipid Hybrid Nanocarriers for Trageted Therapy of Triple-Negative Breast Cancer 

Funded by Boğaziçi University Research Grant Nr. 20417, 08/2025-08/2027

Project title: Development of Biopolymer-Lipid Hybrid Nanocarriers for Targeted Therapy of Triple-Negative Breast Cancer 

Principal Investigator: Banu İyisan

Project Summary: The aim of this project is the development of hybrid nanocarrier systems with a biopolymer shell-lipid core structure, loaded with a chemotherapeutic drug, which can actively target triple-negative breast cancer (TNBC) cells, and the evaluation of their in vitro efficacy.